A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

This publication is sponsored by Insulet Corporation.

This Clinical Brief provides key information regarding the results of a pivotal clinical trial of a tubeless, on-body automated insulin delivery system in pediatric and adult patients with type 1 diabetes. An interview with trial investigators offers insights on the impact of advances in technology on disease management and treatment.